Compliance rates and outcomes associated with a restrictive transfusion policy in gynecologic oncology patients. (abre nova janela)

Boone JD, Kim KH, Marques M, Straughn JM.

Fonte‎: Gynecol Oncol 2014;132(1):227-30.

Indexado‎: PubMed 24512847

DOI‎: 10.1016/j.ygyno.2013.10.019

https://www.ncbi.nlm.nih.gov/pubmed/24512847 (abre nova janela)

Liberal or restrictive transfusion in high-risk patients after hip surgery. (abre nova janela)

Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, Nemo G, Dragert K, Beaupre L, Hildebrand K, Macaulay W, Lewis C, Cook DR, Dobbin G, Zakriya KJ, Apple FS, Horney RA, Magaziner J; FOCUS Investigators.

Fonte‎: N Engl J Med 2011;365(26):2453-62.

Indexado‎: PubMed 22168590

DOI‎: 10.1056/NEJMoa1012452

https://www.ncbi.nlm.nih.gov/pubmed/22168590 (abre nova janela)

Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient. (abre nova janela)

Chojnowski K, Janus A, Bliźniewska K, Robak M, Treliński J.

Fonte‎: Transfusion 2016;56(10):2438-42.

Indexado‎: PubMed 27385671

DOI‎: 10.1111/trf.13703

https://www.ncbi.nlm.nih.gov/pubmed/27385671 (abre nova janela)

Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (abre nova janela)

Ford PA, Grant SJ, Mick R, Keck G.

Fonte‎: J Clin Oncol 2015;33(15):1674-9.

Indexado‎: PubMed 25870085

DOI‎: 10.1200/JCO.2014.57.9912

https://www.ncbi.nlm.nih.gov/pubmed/25870085 (abre nova janela)

Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions. (abre nova janela)

Friedmann AM, Sengul H, Lehmann H, Schwartz C, Goodman S.

Fonte‎: Transfus Med Rev 2002;16(1):34-45.

Indexado‎: PubMed 11788928

https://www.ncbi.nlm.nih.gov/pubmed/11788928 (abre nova janela)

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. (abre nova janela)

Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E; Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.

Fonte‎: N Engl J Med 1999;340(6):409-17.

Indexado‎: PubMed 9971864

DOI‎: 10.1056/NEJM199902113400601

https://www.ncbi.nlm.nih.gov/pubmed/9971864 (abre nova janela)

Red blood cell transfusion in non-bleeding critically ill patients with moderate anemia: is there a benefit? (abre nova janela)

Leal-Noval SR, Muñoz-Gómez M, Jiménez-Sánchez M, Cayuela A, Leal-Romero M, Puppo-Moreno A, Enamorado J, Arellano-Orden V.

Fonte‎: Intensive Care Med 2013;39(3):445-53.

Indexado‎: PubMed 23184038

DOI‎: 10.1007/s00134-012-2757-z

https://www.ncbi.nlm.nih.gov/pubmed/23184038 (abre nova janela)

How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology. (abre nova janela)

Prescott LS, Taylor JS, Lopez-Olivo MA, Munsell MF, VonVille HM, Lairson DR, Bodurka DC.

Fonte‎: Cancer Treat Rev 2016;46:1-8.

Indexado‎: PubMed 27046422

DOI‎: 10.1016/j.ctrv.2016.03.010

https://www.ncbi.nlm.nih.gov/pubmed/27046422 (abre nova janela)

Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. (abre nova janela)

Roubinian NH, Escobar GJ, Liu V, Swain BE, Gardner MN, Kipnis P, Triulzi DJ, Gottschall JL, Wu Y, Carson JL, Kleinman SH, Murphy EL; NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS-III).

Fonte‎: Transfusion 2014;54(10 Pt 2):2678-86.

Indexado‎: PubMed 25135770

DOI‎: 10.1111/trf.12825

https://www.ncbi.nlm.nih.gov/pubmed/25135770 (abre nova janela)

Liberal versus restrictive red blood cell transfusion thresholds in hematopoietic cell transplantation: a randomized, open label, phase III, noninferiority trial. (abre nova janela)

Tay J, Allan DS, Chatelain E, Coyle D, Elemary M, Fulford A, Petrcich W, Ramsay T, Walker I, Xenocostas A, Tinmouth A, Fergusson D

Fonte‎: J Clin Oncol 2020;38(13):1463-73.

Indexado‎: PubMed 32083994

DOI‎: 10.1200/JCO.19.01836

https://www.ncbi.nlm.nih.gov/pubmed/32083994 (abre nova janela)

Transfusion indications for patients with cancer. (abre nova janela)

Watkins T, Surowiecka MK, McCullough J.

Fonte‎: Cancer Control 2015;22(1):38-46.

Indexado‎: PubMed 25504277

https://www.ncbi.nlm.nih.gov/pubmed/25504277 (abre nova janela)

Restrictive blood transfusion protocol in malignant upper gastrointestinal and pancreatic resections patients reduces blood transfusions with no increase in patient morbidity. (abre nova janela)

Wehry J, Agle S, Philips P, Cannon R, Scoggins CR, Puffer L, McMasters KM, Martin RC.

Fonte‎: Am J Surg 2015;210(6):1197-204.

Indexado‎: PubMed 26602534

DOI‎: 10.1016/j.amjsurg.2015.08.013

https://www.ncbi.nlm.nih.gov/pubmed/26602534 (abre nova janela)